<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="bottom"> Concomitant Drug </td>
<td align="center" stylecode="     Botrule          Toprule          Rrule     " valign="bottom"> Effect on Concentration of Lamotrigine or Concomitant Drug</td>
<td align="center" stylecode="     Botrule          Toprule          Rrule     " valign="bottom"> Clinical Comment</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</td>
<td stylecode="     Rrule     " valign="top"> ↓ lamotrigine</td>
<td stylecode="     Rrule     " valign="top"> Decreased lamotrigine levels approximately 50%.</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> </td>
<td stylecode="     Botrule          Rrule     " valign="top"> ↓ levonorgestrel</td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decrease in levonorgestrel component by 19%.</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> Carbamazepine (CBZ) and CBZ epoxide</td>
<td stylecode="     Rrule     " valign="top"> ↓ lamotrigine</td>
<td stylecode="     Rrule     " valign="top"> Addition of carbamazepine decreases lamotrigine concentration approximately 40%.</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> </td>
<td stylecode="     Botrule          Rrule     " valign="top"> ? CBZ epoxide</td>
<td stylecode="     Botrule          Rrule     " valign="top"> May increase CBZ epoxide levels </td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> Phenobarbital/Primidone</td>
<td stylecode="     Botrule          Rrule     " valign="top"> ↓ lamotrigine</td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased lamotrigine concentration approximately 40%.</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> Phenytoin (PHT)</td>
<td stylecode="     Botrule          Rrule     " valign="top"> ↓ lamotrigine</td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased lamotrigine concentration approximately 40%.</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> Rifampin</td>
<td stylecode="     Botrule          Rrule     " valign="top"> ↓ lamotrigine</td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased lamotrigine AUC approximately 40%.</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> Valproate</td>
<td stylecode="     Rrule     " valign="top"> ↑ lamotrigine</td>
<td stylecode="     Rrule     " valign="top"> Increased lamotrigine concentrations slightly more than 2-fold.</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> </td>
<td stylecode="     Botrule          Rrule     " valign="top"> ? valproate</td>
<td stylecode="     Botrule          Rrule     " valign="top"> Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients. </td>
</tr>
</tbody>
</table>